メニエール病のイソバイド療法 : 投与法の検討 Oral administration therapy of isosorbide (ISOBIDE^【○!R】) for Meniere's disease : Methods of the medication in cases with different serum osmotic pressure

この論文にアクセスする

この論文をさがす

著者

抄録

Hyperosmotic solution of isosorbide has been used for treatment of Meniere's disease since Kitahara et al., Larsen et al. and Nozawa et al.. In recent studies reported that ADH is acting to open water channels, AQP-2 at the endlymphatic membrane and may act worse for labyrinthine hydrops. It is important the serum concentration of isosorbide after administration because ADH should be released if the serum osmotic pressure is elevated by isosorbide above more than 2% of normal serum osmotic pressure. In this study the equation predicting isosrbide serum concentration after oral administration was proposed on the basis of the data by Wakiya's report. It was confirmed the serum osmotic pressure remains below the threshold level for increasing ADH secretion by the routine method of 30 ml/once, 3 times every day. However, the method of 30 ml/once, single or two times every day should be recommended when the serum osmotic pressure before the medication is above 289 mOsm/kg.

収録刊行物

  • Equilibrium research  

    Equilibrium research 66(2), 64-72, 2007-04-01 

    Japan Society for Equilibrium Research

参考文献:  17件

参考文献を見るにはログインが必要です。ユーザIDをお持ちでない方は新規登録してください。

各種コード

  • NII論文ID(NAID)
    10021290125
  • NII書誌ID(NCID)
    AN00001485
  • 本文言語コード
    JPN
  • 資料種別
    ART
  • ISSN
    03855716
  • データ提供元
    CJP書誌  J-STAGE 
ページトップへ